Product · #21 of 27 · menopause + gut/metabolism
MenoLabs MenoFit
Capsule from MenoLabs, made by MenoLabs (Dr. Reddy's). Daily serving: 2 capsules in the morning.
Last updated · Price and ratings checked Nov 19, 2026
In short: MenoLabs MenoFit scores 46.3/100 in our ranking (#21 of 27). It costs $1.67 a day at the regular price. Evidence: probiotics: weak evidence; best ingredient grade C+ (Red clover). No NSF registry listing was confirmed.
Pros
- None stood out.
Cons
- No NSF registry listing confirmed (the brand says it is third-party tested).
- Expensive: $1.67 a day at the label dose.
- Evidence: probiotics: weak evidence.
- Proprietary blend: some ingredient amounts are not disclosed.
Flags
FTC noticeWatchdog complaintDrug interactions
Score breakdown
Full label: what's in it
| Ingredient (as labeled) | Per day | Evidence page |
|---|---|---|
| Probiotic blend (L. gasseri, L. reuteri, L. plantarum, B. lactis) 96 mg / 25 billion CFU | 96 mg | Probiotics C- |
| MenoFit Support Blend: chaste tree berry, dong quai, red clover, magnolia bark, berberine HCl, bitter melon, R-alpha-lipoic acid (proprietary total) | 375 mg | Red clover C+ Vitex (chasteberry) C- |
| Prebiotic stabilizer: Jerusalem artichoke inulin, tocotrienols, acacia, resveratrol, sunflower lecithin, rice bran (total) | 209 mg | Not in our evidence library |
| Vitamin C | 55 mg | Not in our evidence library |
| Vitamin D3 | 20 mcg | Vitamin D & calcium B |
| Vitamin K2 (MK-7) | 60 mcg | Not in our evidence library |
| Riboflavin | 20 mg | Not in our evidence library |
| Vitamin B6 (P5P) | 25 mg | Not in our evidence library |
| Folate (5-MTHF) | 680 mcg DFE | Not in our evidence library |
| Vitamin B12 | 400 mcg | Not in our evidence library |
| Calcium | 26 mg | Vitamin D & calcium B |
| Zinc | 11 mg | Not in our evidence library |
| Benfotiamine | 25 mg | Not in our evidence library |
| Haematococcus extract (2% astaxanthin) | 15 mg | Not in our evidence library |
Heavy proprietary blends; the red clover amount is not disclosed.
Evidence
Our evidence score: 14/40, because: probiotics: weak evidence.
Product-level research: we found no published trial of this exact product, so its evidence comes from studies of its ingredients.
Ingredient evidence
- Probiotics C- (96 mg here)
Probiotics support digestive health*. Only one strain (L. acidophilus YT1) has a menopause-symptom trial, and it is not in any product we ranked; effects on bone are mixed. The Menopause Society 2023: L. acidophilus YT1 not recommended (Level II). - Red clover C+ (375 mg here)
Red clover isoflavones have been studied for occasional hot flashes*. Some meta-analyses report short-term effects, but a 12-month NIH-funded trial and a Cochrane review found no clear benefit over placebo. The Menopause Society 2023: Not specifically named (supplements not recommended). - Vitex (chasteberry) C- (375 mg here)
Vitex (chasteberry) has better evidence for menstrual-cycle comfort than for menopause. The largest menopause trial (100 women, combined with St John's wort) found no benefit over placebo. The Menopause Society 2023: Not recommended (Level II). - Vitamin D & calcium B (20 mcg here)
Calcium and vitamin D support bone health*. Large trials, including the Women's Health Initiative, show a small effect on bone density, and effects on fractures are mixed. The Menopause Society 2023: Not part of VMS statement.
Studies
Studies on its ingredients (10)
-
The Effect of Lactobacillus acidophilus YT1 (MENOLACTO) on Improving Menopausal Symptoms: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
67 Korean women took a specific probiotic strain or placebo for 12 weeks; overall menopause scores improved. It is the only trial of its kind and NAMS did not recommend it.
- Who
- 67 women (Korea)
- Dose
- Lactobacillus acidophilus YT1 (MENOLACTO) 1×10^8 CFU/day
- Duration
- 12 weeks
- Result
- Kupperman Index and MENQOL improved vs placebo; no hormone or endometrial changes.
- Funding
- Authors declared no conflicts. Independent / academic
-
Limosilactobacillus reuteri 6475 and Prevention of Early Postmenopausal Bone Loss: A Randomized Clinical Trial.
239 Swedish women took a probiotic or placebo for 2 years. The probiotic did not slow bone loss.
- Who
- 239 early-postmenopausal women
- Dose
- Limosilactobacillus reuteri 6475 (2 doses)
- Duration
- 2 years
- Result
- No effect on bone loss or bone turnover vs placebo.
- Funding
- Industry partner BioGaia (strain owner) per paper (not verified in abstract); independent stats. Industry-linked
-
Effects of probiotic supplementation on bone health in postmenopausal women: a systematic review and meta-analysis.
Pooling 12 trials, probiotics were linked to slightly better bone density in postmenopausal women, though the largest single trial was negative.
- Who
- 12 RCTs, 1,183 women
- Dose
- various probiotics
- Duration
- various
- Result
- Higher spine (SMD 0.60) and hip BMD (SMD 0.74) vs control.
- Funding
- Academic (China). Independent / academic
-
Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial.
In a year-long, government-funded trial, women took black cohosh, red clover, hormone therapy or a dummy pill. Only hormones beat placebo for hot flashes; both herbs looked safe but did not reduce hot flashes more than placebo.
- Who
- 89 women (4 arms)
- Dose
- standardized black cohosh and red clover extracts vs CEE/MPA vs placebo
- Duration
- 12 months
- Result
- Hot-flash reduction: black cohosh 34%, red clover 57%, placebo 63%, hormones 94%; neither botanical beat placebo. Both appeared safe over 12 months.
- Funding
- NIH (NCCAM/ODS) botanical center, University of Illinois – independent. Independent / academic
-
Phytoestrogens for menopausal vasomotor symptoms.
An independent Cochrane review of 43 trials found no conclusive proof that phytoestrogens (soy, red clover) reduce hot flashes. High-genistein soy extracts looked more promising, and placebo effects were large.
- Who
- 43 RCTs, 4,364 women
- Dose
- various phytoestrogens
- Duration
- various
- Result
- No conclusive evidence of reduced hot flushes; Promensil (red clover) not better than placebo (MD -0.93/day, NS); genistein >30 mg/day may help; strong placebo effect.
- Funding
- Cochrane review (independent). Independent / academic
-
Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.
A JAMA analysis of 62 studies found plant estrogens such as soy cut about one hot flash a day compared with placebo – a modest effect – and most studies were of low quality.
- Who
- 62 studies, 6,653 women
- Dose
- phytoestrogens and other plant therapies
- Duration
- various
- Result
- Phytoestrogens: -1.31 hot flashes/day; soy isoflavones -0.79/day; 74% of RCTs at high risk of bias.
- Funding
- Academic (Erasmus MC); industry co-funding reported in paper is not verified here. Industry-linked
-
Evaluation of Clinical Meaningfulness of Red Clover (Trifolium pratense L.) Extract to Relieve Hot Flushes and Menopausal Symptoms in Peri- and Post-Menopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Pooling 8 trials, red clover reduced hot flashes by about 1–2 a day more than placebo, mostly in women with frequent hot flashes taking higher doses.
- Who
- 8 trials (10 comparisons)
- Dose
- red clover isoflavones
- Duration
- ~12 weeks
- Result
- -1.73 hot flushes/day vs placebo (95% CI -3.28 to -0.18), mainly in women with ≥5/day and ≥80 mg isoflavones.
- Funding
- Authors declared no conflicts. Independent / academic
-
Red clover extract for alleviating hot flushes in postmenopausal women: a meta-analysis.
A review found red clover modestly reduced hot flashes over 3–4 months, but the benefit was no longer seen at 12 months.
- Who
- meta-analysis
- Dose
- red clover extract
- Duration
- 3–4 months and 12 months
- Result
- Effective at 3–4 months (MD -1.34/day) but not at 12 months.
- Funding
- Academic (Monash). Independent / academic
-
Hypericum perforatum with Vitex agnus-castus in menopausal symptoms: a randomized, controlled trial.
100 Australian women took a St John's wort + chasteberry combination or placebo for 16 weeks. It did not beat placebo – the largest, most rigorous vitex trial.
- Who
- 100 women
- Dose
- St John's wort + Vitex combination
- Duration
- 16 weeks
- Result
- No difference vs placebo for hot flushes, Greene scale or depression.
- Funding
- Academic (Australia). Independent / academic
-
Comparison of Vitex agnus-castus Extracts with Placebo in Reducing Menopausal Symptoms: A Randomized Double-Blind Study.
52 Iranian women took chasteberry or placebo for 8 weeks; symptom questionnaires improved more with vitex. Small and questionnaire-based.
- Who
- 52 women (Iran)
- Dose
- Vitex agnus-castus extract
- Duration
- 8 weeks
- Result
- Total menopausal, anxiety and vasomotor scores lower vs placebo.
- Funding
- No conflicts reported. Independent / academic
The Menopause Society's 2023 statement is in the study library.
Price
| Regular one-time price | $49.99 (60 units, 30 days at label dose) |
|---|---|
| Cost per day | $1.67 |
| Subscription | Amazon S&S $35.99 |
| Price notes | 3-pack $127.99; Amazon B084MM9VNS $40.00 (list $44.99). MenoFit Advanced $54.99 also sold. |
| In stock when checked | Yes |
| Checked | Nov 19, 2026 |
Ratings
Amazon: ★ 4 from 4,059 ratings on Amazon (checked Nov 19, 2026)
Brand site: no average shown, 566 reviews on menolabs.com (checked Nov 19, 2026). 86% 5-star (485/566); some reviews from related products. Brand-site reviews are moderated by the brand.
Star ratings reflect buyer satisfaction, not clinical effect.
Certifications and claims
Verified in a public registry
- No registry listing found.
Claims made by the brand
- “third-party tested for quality” Brand claim
- “manufactured under cGMP” Brand claim
- “RD approved” Brand claim
- “no artificial colors/flavors” Brand claim
Registry check: NSF/ANSI 173 ('MenoLabs'): not found
Who's behind it
| Brand | MenoLabs |
|---|---|
| Owner / company | MenoLabs (Princeton, NJ) – subsidiary of Dr. Reddy's Laboratories, Inc. (per TINA.org letter). |
| Founders | Founded 2020 by 'two longtime friends'; co-founder Danielle Jacobs named in TINA letter. |
| Where it's made | not stated on brand page. |
| Medical advisors named |
|
| Source | menolabs.com |
Flags & safety
Legal, regulatory and quality flags
- TINA.org letter (Oct 2024) re MenoFit/MenoGlow claims; parent Dr. Reddy's received FTC Notice of Penalty Offenses (2023). truthinadvertising.org
- Contains refined soybean oil; berberine (drug interactions).
Ingredient safety notes
- Probiotics: Generally safe; strain-specific.
- Red clover: Phytoestrogen – same caution as isoflavones in hormone-sensitive conditions; 12-month safety acceptable in Geller 2009.
- Vitex (chasteberry): Few AEs; avoid with dopaminergic drugs/hormonal contraception (general caution).
- Vitamin D & calcium: Kidney stones increased (WHI HR 1.17). WHI long-term follow-up: CVD mortality HR 1.06, cancer mortality HR 0.93.
Not verified
- “Third-party tested” claim (no public registry listing found). Unverified
Sources
Talk to a clinician first
The Menopause Society's 2023 nonhormone position statement does not recommend any dietary supplement or herbal remedy for hot flashes, because the research is limited or mixed. Hormone therapy is an option for many women, and the statement lists non-hormonal options with evidence behind them: CBT, clinical hypnosis, SSRIs/SNRIs, gabapentin, fezolinetant (Level I), oxybutynin (I–II), weight loss, stellate ganglion block (II–III).
If hot flashes, night sweats, sleep or mood are affecting your life, talk to a clinician first. If you still want to try a supplement, the rankings below show what is actually in each one, what the research found, and who is behind it. Sources: position statement (PDF) · PubMed.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.